Studies on the polymorphism of carbromal

Area of Science:

• Pharmaceutical Chemistry
• Solid-State Chemistry

Background:

• Carbromal is a sedative-hypnotic drug.
• Polymorphism, the ability of a solid material to exist in multiple crystalline forms, can significantly impact drug properties.

Purpose of the Study:

• To investigate the polymorphic forms of carbromal.
• To assess the stability and pharmacological differences of carbromal polymorphs.

Main Methods:

• Crystallization of carbromal from various solvents.
• Analysis of polymorphic forms after a 9-month storage period.
• Preliminary pharmacological testing of different carbromal forms.

Main Results:

• Three polymorphic forms (I, II, and III) of carbromal were identified.
• Metastable form III, obtained from dimethylformamide, demonstrated notable stability.
• Significant differences in therapeutic effects were observed between a commercial carbromal specimen and polymorphic form III.

Conclusions:

• Carbromal exists in multiple polymorphic forms.
• The stability and pharmacological activity of carbromal are influenced by its polymorphic form.
• Polymorphism is a critical consideration for the medicinal use of carbromal.